Accessibility: Skip TopNav
Chi Li
Editas Medicine today announced that it named Chi Li, Ph.D., MBA, RAC, as the Company’s Senior Vice President and Chief Regulatory Officer.
Format
JPEG
Source
Editas Medicine, Inc.
Downloads
Original
Large
Medium
Small